PURPOSE: Cis-acting regulatory SNPs resulting in differential allelic expression (DAE) may, in part, explain the underlying phenotypic variation associated with many complex diseases. To investigate whether common variants associated with DAE were involved in breast cancer susceptibility among BRCA1 and BRCA2 mutation carriers, a list of 175 genes was developed based of their involvement in cancer-related pathways. METHODS: Using data from a genome-wide map of SNPs associated with allelic expression, we assessed the association of ~320 SNPs located in the vicinity of these genes with breast and ovarian cancer risks in 15,252 BRCA1 and 8211 BRCA2 mutation carriers ascertained from 54 studies participating in the Consortium of Investigators of Modifiers of BRCA1/2. RESULTS: We identified a region on 11q22.3 that is significantly associated with breast cancer risk in BRCA1 mutation carriers (most significant SNP rs228595 p = 7 × 10-6). This association was absent in BRCA2 carriers (p = 0.57). The 11q22.3 region notably encompasses genes such as ACAT1, NPAT, and ATM. Expression quantitative trait loci associations were observed in both normal breast and tumors across this region, namely for ACAT1, ATM, and other genes. In silico analysis revealed some overlap between top risk-associated SNPs and relevant biological features in mammary cell data, which suggests potential functional significance. CONCLUSION: We identified 11q22.3 as a new modifier locus in BRCA1 carriers. Replication in larger studies using estrogen receptor (ER)-negative or triple-negative (i.e., ER-, progesterone receptor-, and HER2-negative) cases could therefore be helpful to confirm the association of this locus with breast cancer risk.

Bâtiment Cheney D Centre Léon Bérard 28 rue Laënnec 69373 Lyon France

Biomedical Network on Rare Diseases 28029 Madrid Spain

Biomedical Sciences Institute University of Porto Porto Portugal

BMC Faculty of Medicine University of Iceland Vatnsmyrarvegi 16 101 Reykjavík Iceland

Cancer Bioimmunotherapy Unit Department of Medical Oncology Centro di Riferimento Oncologico IRCCS National Cancer Institute Via Franco Gallini 2 33081 Aviano PN Italy

Cancer Genetics Laboratory Department of Genetics University of Pretoria Private Bag X323 Arcadia 0007 South Africa

Cancer Research Initiatives Foundation Sime Darby Medical Centre 1 Jalan SS12 1A 47500 Subang Jaya Malaysia

Cancer Risk and Prevention Clinic Dana Farber Cancer Institute 450 Brookline Avenue Boston MA USA

Center for Clinical Epidemiology and Biostatistics Perelman School of Medicine at the University of Pennsylvania Philadelphia PA USA

Center for Genomic Medicine Rigshospitalet Copenhagen University Hospital Blegdamsvej 9 2100 Copenhagen Denmark

Center for Hereditary Breast and Ovarian Cancer Medical Faculty University Hospital Cologne 50931 Cologne Germany

Center for Integrated Oncology Medical Faculty University Hospital Cologne Cologne Germany

Center for Medical Genetics Ghent University De Pintelaan 185 9000 Ghent Belgium

Center for Medical Genetics NorthShore University HealthSystem University of Chicago Pritzker School of Medicine 1000 Central Street Suite 620 Evanston IL 60201 USA

Centre for Cancer Genetic Epidemiology Department of Public Health and Primary Care University of Cambridge Strangeways Research Laboratory Worts Causeway Cambridge UK

Centre François Baclesse 3 avenue Général Harris 14076 Caen France

Centre of Familial Breast and Ovarian Cancer Department of Gynaecology and Obstetrics and Centre for Integrated Oncology University Hospital of Cologne 50931 Cologne Germany

City of Hope Clinical Cancer Genomics Community Research Network 1500 East Duarte Road Duarte CA 91010 USA

Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology Carmel Medical Center and B Rappaport Faculty of Medicine 7 Michal St 34362 Haifa Israel

Clinical Cancer Genetics City of Hope 1500 East Duarte Road Duarte CA 91010 USA

Clinical Genetics Branch DCEG NCI NIH 9609 Medical Center Drive Room 6E 454 Bethesda MD USA

Clinical Genetics Guy's and St Thomas' NHS Foundation Trust London SE1 9RT UK

Clinical Genetics Research Laboratory Department of Medicine Memorial Sloan Kettering Cancer Center 1275 York Avenue New York NY 10044 USA

Clinical Genetics Service Department of Medicine Memorial Sloan Kettering Cancer Center 1275 York Avenue New York NY USA

Clinical Genetics Services Department of Medicine Memorial Sloan Kettering Cancer Center 1275 York Avenue New York NY 10065 USA

Comprehensive Cancer Center Arthur C James Cancer Hospital and Richard J Solove Research Institute Biomedical Research Tower Room 588 460 West 12th Avenue Columbus OH 43210 USA

Department of Breast Medical Oncology and Clinical Cancer Genetics Program University of Texas MD Anderson Cancer Center 1515 Pressler Street CBP 5 Houston TX 77030 USA

Department of Cancer Epidemiology and Genetics Masaryk Memorial Cancer Institute Zluty kopec 7 65653 Brno Czech Republic

Department of Cancer Epidemiology Moffitt Cancer Center Tampa FL 33612 USA

Department of Cancer Genetics Institute for Cancer Research Oslo University Hospital Radiumhospitalet 0372 Oslo Norway

Department of Clincial Genetics Rigshospitalet Blegdamsvej 9 4062 Copenhagen Denmark

Department of Clinical Genetics Aarhus University Hospital Brendstrupgaardsvej 21C Århus N Denmark

Department of Clinical Genetics Academic Medical Center P O Box 22700 1100 DE Amsterdam The Netherlands

Department of Clinical Genetics Family Cancer Clinic Erasmus University Medical Center 330 Brookline Avenue P O Box 2040 3000 CA Rotterdam The Netherlands

Department of Clinical Genetics Helsinki University Hospital HUS Meilahdentie 2 P O BOX 160 00029 Helsinki Finland

Department of Clinical Genetics Karolinska University Hospital L5 03 171 76 Stockholm Sweden

Department of Clinical Genetics Maastricht University Medical Center P O Box 5800 6202 AZ Maastricht The Netherlands

Department of Clinical Genetics Odense University Hospital Sonder Boulevard 29 Odense C Denmark

Department of Clinical Genetics Royal Devon and Exeter Hospital Exeter EX1 2ED UK

Department of Clinical Genetics South Glasgow University Hospitals Glasgow G51 4TF UK

Department of Clinical Genetics VU University Medical Center P O Box 7057 1007 MB Amsterdam The Netherlands

Department of Dermatology University of Utah School of Medicine 30 North 1900 East SOM 4B454 Salt Lake City UT 84132 USA

Department of Epidemiology Cancer Prevention Institute of California 2201 Walnut Avenue Suite 300 Fremont CA 94538 USA

Department of Epidemiology Columbia University New York NY USA

Department of Epidemiology Netherlands Cancer Institute P O Box 90203 1006 BE Amsterdam The Netherlands

Department of Genetics and Pathology Pomeranian Medical University Polabska 4 70 115 Szczecin Poland

Department of Genetics Portuguese Oncology Institute Rua Dr António Bernardino de Almeida 4200 072 Porto Portugal

Department of Genetics University Medical Center Groningen University of Groningen 9700 RB Groningen The Netherlands

Department of Gynaecology and Obstetrics University Hospital of Schleswig Holstein Christian Albrechts University Kiel Campus Kiel 24105 Kiel Germany

Department of Health Research and Policy and Stanford Cancer Institute Stanford University School of Medicine Stanford CA USA

Department of Health Sciences Research Mayo Clinic 200 1st Street SW Rochester MN 55905 USA

Department of Human Genetics and Department of Clinical Genetics Leiden University Medical Center 2300 RC Leiden The Netherlands

Department of Human Genetics McGill University Montreal QC H3A 1B1 Canada

Department of Human Genetics Radboud University Medical Center P O Box 9101 6500 HB Nijmegen The Netherlands

Department of Laboratory Medicine and Pathology Mayo Clinic 200 1st Street SW Rochester MN 55905 USA

Department of Laboratory Medicine and the Keenan Research Centre of the Li Ka Shing Knowledge Institute St Michael's Hospital Toronto ON Canada

Department of Medical Genetics Level 6 Addenbrooke's Treatment Centre Addenbrooke's Hospital Hills Road Box 134 Cambridge CB2 0QQ UK

Department of Medical Genetics University Medical Center Utrecht 3584 EA Utrecht The Netherlands

Department of Medical Oncology Beth Israel Deaconess Medical Center 330 Brookline Avenue Boston MA 02215 USA

Department of Medical Oncology Family Cancer Clinic Erasmus University Medical Center P O Box 5201 3008 AE Rotterdam The Netherlands

Department of Medical Oncology Papageorgiou Hospital Aristotle University of Thessaloniki School of Medicine Thessaloníki Greece

Department of Medicine Abramson Cancer Center Perelman School of Medicine at the University of Pennsylvania 3400 Civic Center Boulevard Philadelphia PA 19104 USA

Department of Medicine and Genetics University of California 513 Parnassus Ave HSE 901E San Francisco CA 94143 0794 USA

Department of Medicine Huntsman Cancer Institute 2000 Circle of Hope Salt Lake City UT 84112 USA

Department of Medicine University of Chicago 5841 South Maryland Avenue MC 2115 Chicago IL USA

Department of Molecular Genetics National Institute of Oncology Budapest Hungary

Department of OB GYN Medical University of Vienna Waehringer Guertel 18 20 A 1090 Vienna Austria

Department of Obstetrics and Gynecology University of Helsinki and Helsinki University Hospital Biomedicum Helsinki Haartmaninkatu 8 HUS P O BOX 700 00029 Helsinki Finland

Department of Oncology Hospital Clinico San Carlos IdISSC Martin Lagos s n Madrid Spain

Department of Oncology Karolinska University Hospital 17176 Stockholm Sweden

Department of Oncology Lund University Hospital 22185 Lund Sweden

Department of Oncology Rigshospitalet Copenhagen University Hospital Blegdamsvej 9 2100 Copenhagen Denmark

Department of Oncology Sahlgrenska University Hospital 41345 Göteborg Sweden

Department of Pathology and Laboratory Medicine University of Kansas Medical Center 3901 Rainbow Boulevard 4019 Wahl Hall East MS 3040 Kansas City Kansas USA

Department of Pathology and Molecular Medicine Juravinski Hospital and Cancer Centre McMaster University 711 Concession Street Hamilton ON L8V 1C3 Canada

Department of Pathology hus 9 Landspitali LSH v Hringbraut 101 Reykjavík Iceland

Department of Pathology Johns Hopkins University School of Medicine Baltimore MD 21205 USA

Department of Pathology Region Zealand Section Slagelse Slagelse Hospital Ingemannsvej 18 Slagelse Cpoenhagen Denmark

Department of Population Sciences Beckman Research Institute of City of Hope Duarte CA USA

Department of Preventive Medicine Keck School of Medicine University of Southern California Los Angeles CA 90033 USA

Department of Preventive Medicine Seoul National University College of Medicine 103 Daehak ro Jongno gu Seoul 110 799 Korea

Departments of Molecular Genetics and Laboratory Medicine and Pathobiology University of Toronto Toronto ON Canada

Departments of Pediatrics and Medicine Columbia University 1150 St Nicholas Avenue New York NY 10032 USA

Division of Cancer Prevention and Genetics Istituto Europeo di Oncologia Via Ripamonti 435 20141 Milan Italy

Division of Gynecologic Oncology Department of Obstetrics and Gynecology The Ohio State University Columbus OH 43210 USA

Division of Gynecologic Oncology NorthShore University HealthSystem University of Chicago 2650 Ridge Avenue Suite 1507 Walgreens Evanston IL 60201 USA

Division of Human Genetics Departments of Internal Medicine and Cancer Biology and Genetics Comprehensive Cancer Center The Ohio State University 998 Biomedical Research Tower Columbus OH 43210 USA

Division of Medical Oncology Department of Internal Medicine The Ohio State University Columbus OH 43210 USA

Division of Population Science Fox Chase Cancer Center 333 Cottman Avenue Philadelphia PA 19111 USA

Faculty of Medicine University of Southampton Southampton University Hospitals NHS Trust Southampton UK

Familial Cancer Centre Peter MacCallum Cancer Centre Melbourne VIC 3000 Australia

Family Cancer Clinic Netherlands Cancer Institute P O Box 90203 1006 BE Amsterdam The Netherlands

Genetic Counseling Unit Hereditary Cancer Program IDIBELL Catalan Institute of Oncology Gran Via de l'Hospitalet 199 203 L'Hospitalet 08908 Barcelona Spain

Genetic Epidemiology Laboratory Department of Pathology University of Melbourne Parkville VIC 3010 Australia

Genetic Epidemiology of Cancer Team INSERM U900 Institut Curie Mines ParisTech PSL University 26 rue d'Ulm 75248 Paris Cedex 05 France

Genetics and Computational Biology Department QIMR Berghofer Medical Research Institute Herston Road Brisbane QLD 4006 Australia

Genomic Medicine Manchester Academic Health Sciences Centre Institute of Human Development Manchester University Central Manchester University Hospitals NHS Foundation Trust Manchester M13 9WL UK

Genomics Center Centre Hospitalier Universitaire de Québec Research Center and Laval University 2705 Laurier Boulevard Quebec QC G1V 4G2 Canada

Hematology Oncology and Transfusion Medicine Center Department of Molecular and Regenerative Medicine Vilnius University Hospital Santariskiu Clinics Santariskiu st 2 08661 Vilnius Lithuania

Human Genetics Group Spanish National Cancer Centre Madrid Spain

Human Genotyping Madrid Spain

IFOM The FIRC Institute of Molecular Oncology c o IFOM IEO Campus Via Adamello 16 20139 Milan Italy

Immunology and Molecular Oncology Unit Veneto Institute of Oncology IOV IRCCS Via Gattamelata 64 35128 Padua Italy

Institute for Medical Informatics Statistics and Epidemiology University of Leipzig 04107 Leipzig Germany

Institute of Human Genetics Charite Berlin Campus Virchov Klinikum 13353 Berlin Germany

Institute of Human Genetics Department of Human Genetics University Hospital Heidelberg Heidelberg Germany

Institute of Human Genetics University of Ulm 89091 Ulm Germany

Laboratoire de génétique médicale Nancy Université Centre Hospitalier Régional et Universitaire Rue du Morvan cedex 1 54511 Vandoeuvre les Nancy France

Latvian Biomedical Research and Study Centre Ratsupites str 1 Riga Latvia

LIFE Leipzig Research Centre for Civilization Diseases University of Leipzig Leipzig Germany

Lombardi Comprehensive Cancer Center Georgetown University 3800 Reservoir Road NW Washington DC 20007 USA

Lunenfeld Tanenbaum Research Institute Mount Sinai Hospital Toronto ON M5G 1X5 Canada

Lyon Neuroscience Research Center CRNL INSERM U1028 CNRS UMR5292 University of Lyon Lyon France

McGill University and Genome Quebec Innovation Centre Montreal QC H3A 0G1 Canada

Medical Genetics Unit St George's University of London London SW17 0RE UK

Molecular Diagnostic Unit Hereditary Cancer Program IDIBELL Catalan Institute of Oncology Gran Via de l'Hospitalet 199 203 L'Hospitalet 08908 Barcelona Spain

Molecular Diagnostics Laboratory Institute of Nuclear and Radiological Sciences and Technology National Centre for Scientific Research Demokritos Patriarchou Gregoriou and Neapoleos str Aghia Paraskevi Attikis Athens Greece

Molecular Genetics of Breast Cancer German Cancer Research Center Im Neuenheimer Feld 580 69120 Heidelberg Germany

Molecular Oncology Laboratory Hospital Clinico San Carlos IdISSC Martin Lagos s n Madrid Spain

N N Petrov Institute of Oncology St Petersburg Russia 197758

NRG Oncology Statistics and Data Management Center Roswell Park Cancer Institute Elm St and Carlton St Buffalo NY 14263 USA

Oncogenetics Group Vall d'Hebron Institute of Oncology Vall d'Hebron University Hospital Clinical and Molecular Genetics Area Passeig Vall d'Hebron 119 129 08035 Barcelona Spain

Oncogenetics Team The Institute of Cancer Research and Royal Marsden NHS Foundation Trust Sutton SM2 5NG UK

Oncogénétique Institut Bergonié 229 cours de l'Argonne 33076 Bordeaux France

Program in Cancer Genetics Departments of Human Genetics and Oncology McGill University Montreal QC Canada

Sackler Faculty of Medicine Tel Aviv University 69978 Ramat Aviv Israel

Section of Genetic Oncology Department of Laboratory Medicine University and University Hospital of Pisa Pisa Italy

Section of Molecular Diagnostics Department of Biochemistry Aalborg University Hospital Reberbansgade 15 Ålborg Denmark

Service de Génétique Oncologique Institut Curie 26 rue d'Ulm 75248 Paris Cedex 05 France

Sir Peter MacCallum Department of Oncology University of Melbourne Melbourne VIC 3010 Australia

State Research Institute Centre for Innovative Medicine Zygymantu st 9 Vilnius Lithuania

The Susanne Levy Gertner Oncogenetics Unit Institute of Human Genetics Chaim Sheba Medical Center 52621 Ramat Gan Israel

The Wellcome Trust Sanger Institute Wellcome Trust Genome Campus Hinxton Cambridge CB10 1HH UK

UCLA Schools of Medicine and Public Health Division of Cancer Prevention and Control Research Jonsson Comprehensive Cancer Center 650 Charles Young Drive South Room A2 125 HS Los Angeles CA 90095 6900 USA

Unit of Medical Genetics Department of Biomedical Experimental and Clinical Sciences University of Florence Viale Morgagni 50 50134 Florence Italy

Unit of Medical Genetics Department of Preventive and Predictive Medicine Fondazione IRCCS Via Giacomo Venezian 1 20133 Milan Italy

Unit of Molecular Bases of Genetic Risk and Genetic Testing Department of Preventive and Predicted Medicine Fondazione IRCCS c o Amaedeolab via GA Amadeo 42 20133 Milan Italy

Unité de Prévention et d'Epidémiologie Génétique Centre Léon Bérard 28 rue Laënnec 69373 Lyon France

Unité de recherche en santé des populations Centre des maladies du sein Deschênes Fabia Hôpital du Saint Sacrement 1050 chemin Sainte Foy Quebec QC G1S 4L8 Canada

University Malaya Cancer Research Institute University Malaya 1 Jalan SS12 1A 50603 Kuala Lumpur Malaysia

University of Queensland Diamantina Institute Translational Research Institute Brisbane QLD Australia

West Midlands Regional Genetics Service Birmingham Women's Hospital Healthcare NHS Trust Edgbaston Birmingham UK

Westmead Hospital Familial Cancer Service Hawkebury Road P O Box 533 Wentworthville NSW 2145 Australia

Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute Cedars Sinai Medical Center 8700 Beverly Boulevard Suite 290W Los Angeles CA 90048 USA

Yorkshire Regional Genetics Service Chapel Allerton Hospital Leeds LS7 4SA UK

Zobrazit více v PubMed

Begg CB, Haile RW, Borg A, Malone KE, Concannon P, Thomas DC, et al. Variation of breast cancer risk among BRCA1/2 carriers. JAMA. 2008;299:194–201. doi: 10.1001/jama.2007.55-a. PubMed DOI PMC

Mavaddat N, Peock S, Frost D, Ellis S, Platte R, Fineberg E, et al. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst. 2013;105:812–822. doi: 10.1093/jnci/djt095. PubMed DOI

Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol. 2007;25:1329–1333. doi: 10.1200/JCO.2006.09.1066. PubMed DOI PMC

Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003;72:1117–1130. doi: 10.1086/375033. PubMed DOI PMC

Simchoni S, Friedman E, Kaufman B, Gershoni-Baruch R, Orr-Urtreger A, Kedar-Barnes I, et al. Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population. Proc Natl Acad Sci USA. 2006;103:3770–3774. doi: 10.1073/pnas.0511301103. PubMed DOI PMC

Rebbeck TR, Mitra N, Wan F, Sinilnikova OM, Healey S, McGuffog L, et al. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. JAMA. 2015;313:1347–1361. doi: 10.1001/jama.2014.5985. PubMed DOI PMC

Friebel TM, Domchek SM, Rebbeck TR. Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis. J Natl Cancer Inst. 2014;106:dju091. doi: 10.1093/jnci/dju091. PubMed DOI PMC

Gaudet MM, Kuchenbaecker KB, Vijai J, Klein RJ, Kirchhoff T, McGuffog L, et al. Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk. PLoS Genet. 2013;9:e1003173. doi: 10.1371/journal.pgen.1003173. PubMed DOI PMC

Couch FJ, Wang X, McGuffog L, Lee A, Olswold C, Kuchenbaecker KB, et al. Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet. 2013;9:e1003212. doi: 10.1371/journal.pgen.1003212. PubMed DOI PMC

Barnes DR, Antoniou AC. Unravelling modifiers of breast and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: update on genetic modifiers. J Intern Med. 2012;271:331–343. doi: 10.1111/j.1365-2796.2011.02502.x. PubMed DOI

Freedman ML, Monteiro AN, Gayther SA, Coetzee GA, Risch A, Plass C, et al. Principles for the post-GWAS functional characterization of cancer risk loci. Nat Genet. 2011;43:513–518. doi: 10.1038/ng.840. PubMed DOI PMC

Maurano MT, Humbert R, Rynes E, Thurman RE, Haugen E, Wang H, et al. Systematic localization of common disease-associated variation in regulatory DNA. Science. 2012;337:1190–1195. doi: 10.1126/science.1222794. PubMed DOI PMC

Li Q, Stram A, Chen C, Kar S, Gayther S, Pharoah P, et al. Expression QTL-based analyses reveal candidate causal genes and loci across five tumor types. Hum Mol Genet. 2014;23:5294–5302. doi: 10.1093/hmg/ddu228. PubMed DOI PMC

Chenevix-Trench G, Milne RL, Antoniou AC, Couch FJ, Easton DF, Goldgar DE, et al. An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA) Breast Cancer Res. 2007;9:104–107. doi: 10.1186/bcr1670. PubMed DOI PMC

Ge B, Pokholok DK, Kwan T, Grundberg E, Morcos L, Verlaan DJ, et al. Global patterns of cis variation in human cells revealed by high-density allelic expression analysis. Nat Genet. 2009;41:1216–1222. doi: 10.1038/ng.473. PubMed DOI

Adoue V, Schiavi A, Light N, Almlöf JC, Lundmark P, Ge B, et al. Allelic expression mapping across cellular lineages to establish impact of non-coding SNPs. Mol Syst Biol. 2014;10:754. doi: 10.15252/msb.20145114. PubMed DOI PMC

Almlöf JC, Lundmark P, Lundmark A, Ge B, Maouche S, Göring HH, et al. Powerful identification of cis-regulatory SNPs in human primary monocytes using allele-specific gene expression. PLoS ONE. 2012;7:e52260. doi: 10.1371/journal.pone.0052260. PubMed DOI PMC

Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 2009;5:e1000529. doi: 10.1371/journal.pgen.1000529. PubMed DOI PMC

Grundberg E, Adoue V, Kwan T, Ge B, Duan QL, Lam KC, et al. Global analysis of the impact of environmental perturbation on cis-regulation of gene expression. PLoS Genet. 2011;7:e1001279. doi: 10.1371/journal.pgen.1001279. PubMed DOI PMC

Barnes DR, Lee A, EMBRACE Investigators. kConFab Investigators. Easton DF, Antoniou AC. Evaluation of association methods for analysing modifiers of disease risk in carriers of high-risk mutations. Genet Epidemiol. 2012;36:274–291. doi: 10.1002/gepi.21620. PubMed DOI

Antoniou AC, Sinilnikova OM, Simard J, Léoné M, Dumont M, Neuhausen SL, et al. RAD51 135G/C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Am J Hum Genet. 2007;81:1186–1200. doi: 10.1086/522611. PubMed DOI PMC

Mulligan AM, Couch FJ, Barrowdale D, Domchek SM, Eccles D, Nevanlinna H, et al. Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Res. 2011;13:R110. doi: 10.1186/bcr3052. PubMed DOI PMC

Teng L, He B, Tan K. 4DGenome: a comprehensive database for chromatin interactions. Bioinformatics. 2015;31:2560–2564. doi: 10.1093/bioinformatics/btv158. PubMed DOI PMC

Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-André V, Sigova AA, et al. Super-enhancers in the control of cell identity and disease. Cell. 2013;155:934–947. doi: 10.1016/j.cell.2013.09.053. PubMed DOI PMC

He B, Chen C, Teng L, Tan K. Global view of enhancer–promoter interactome in human cells. Proc Natl Acad Sci USA. 2014;111:E2191–E2199. doi: 10.1073/pnas.1320308111. PubMed DOI PMC

Beauparlant CJ, Lemacon A, Droit A (2015) ENCODExplorer: a compilation of ENCODE metadata. R package version 1.4.3

Beauparlant CJ, Lamaze F, Deschenes A, Samb R, Lemaçon A, Belleau P, Bilodeau S, Droit A. Metagene profiles analyses reveal regulatory element’s factor-specific recruitment patterns. PLoS Comput Biol. 2016;12:e1004751. doi: 10.1371/journal.pcbi.1004751. PubMed DOI PMC

Aulchenko YS, Ripke S, Isaacs A, Van Duijn CM. GenABEL: an R library for genome-wide association analysis. Bioinformatics. 2007;23:1294–1296. doi: 10.1093/bioinformatics/btm108. PubMed DOI

Fukao T, Yamaguchi S, Kano M, Orii T, Fujiki Y, Osumi T, et al. Molecular cloning and sequence of the complementary DNA encoding human mitochondrial acetoacetyl-coenzyme A thiolase and study of the variant enzymes in cultured fibroblasts from patients with 3-ketothiolase deficiency. J Clin Investig. 1990;86:2086–2092. doi: 10.1172/JCI114946. PubMed DOI PMC

Zhao J, Dynlacht B, Imai T, Hori T, Harlow E. Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry. Genes Dev. 1998;12:456–461. doi: 10.1101/gad.12.4.456. PubMed DOI PMC

Zhao J, Kennedy BK, Lawrence BD, Barbie DA, Matera AG, Fletcher JA, et al. NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription. Genes Dev. 2000;14:2283–2297. doi: 10.1101/gad.827700. PubMed DOI PMC

Saarinen S, Aavikko M, Aittomäki K, Launonen V, Lehtonen R, Franssila K, et al. Exome sequencing reveals germline NPAT mutation as a candidate risk factor for Hodgkin lymphoma. Blood. 2011;118:493–498. doi: 10.1182/blood-2011-03-341560. PubMed DOI

Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science. 1995;268:1749–1753. doi: 10.1126/science.7792600. PubMed DOI

Tavtigian SV, Oefner PJ, Babikyan D, Hartmann A, Healey S, Le Calvez-Kelm F, et al. Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer. Am J Hum Genet. 1009;85:427–446. doi: 10.1016/j.ajhg.2009.08.018. PubMed DOI PMC

Milne RL. Variants in the ATM gene and breast cancer susceptibility. Genome Med. 2009;1:12. doi: 10.1186/gm12. PubMed DOI PMC

Rebbeck TR, Mitra N, Domchek SM, Wan F, Friebel TM, Tran TV, et al. Modification of BRCA1-associated breast and ovarian cancer risk by BRCA1-interacting genes. Cancer Res. 2011;71:5792–5805. doi: 10.1158/0008-5472.CAN-11-0773. PubMed DOI PMC